GCA
MDT icon

Gideon Capital Advisors’s Medtronic MDT Stock Holding History

Gideon Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,855
Closed -$473K – 358
2019
Q2 		$473K Sell
4,855
-768
-14% -$70.1K 0.16% 182
2019
Q1 		$512K Buy
5,623
+774
+16% +$69.3K 0.18% 162
2018
Q4 		$441K Buy
4,849
+695
+17% +$64.9K 0.18% 177
2018
Q3 		$409K Buy
+4,154
New +$384K 0.19% 182
2014
Q4 		– Sell
-15,278
Closed -$946K – 263
2014
Q3 		$946K Buy
+15,278
New +$971K 0.37% 91

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gideon Capital Advisors's MDT Position: Q3 2019 in Review

Gideon Capital Advisors sold out of Medtronic (MDT) in Q3 2019, closing a stake of 4,855 shares — an estimated $473K sold.

Gideon Capital Advisors first reported a position in MDT in Q3 2014 and held it in 5 quarters. The position peaked at $946K in Q3 2014. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Gideon Capital Advisors reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 4,855 Medtronic shares in Q3 2019, an estimated $473K.
  • Gideon Capital Advisors first reported a position in Medtronic in Q3 2014 and held it in 5 quarters.
  • Gideon Capital Advisors's Medtronic position peaked at $946K in Q3 2014.
  • 1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Gideon Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.